> top > docs > PubMed:20696700 > annotations

PubMed:20696700 JSONTXT

Annnotations TAB JSON ListView MergeView

DisGeNET

Id Subject Object Predicate Lexical cue
T0 670-673 gene:7157 denotes p53
T1 857-873 disease:C0006826 denotes malignant tumors
T2 717-721 gene:5460 denotes Oct4
T3 857-873 disease:C0006826 denotes malignant tumors
T4 815-818 gene:7157 denotes p53
T5 857-873 disease:C0006826 denotes malignant tumors
T6 726-730 gene:6657 denotes Sox2
T7 857-873 disease:C0006826 denotes malignant tumors
T8 1380-1383 gene:7157 denotes p53
T9 1453-1468 disease:C0006826 denotes malignant tumor
R1 T0 T1 associated_with p53,malignant tumors
R2 T2 T3 associated_with Oct4,malignant tumors
R3 T4 T5 associated_with p53,malignant tumors
R4 T6 T7 associated_with Sox2,malignant tumors
R5 T8 T9 associated_with p53,malignant tumor

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 238-244 HP_0002664 denotes tumors
T2 867-873 HP_0002664 denotes tumors
T3 1146-1156 HP_0000718 denotes aggressive
T4 1157-1163 HP_0002664 denotes tumors
T5 1302-1308 HP_0002664 denotes tumors
T6 1463-1468 HP_0002664 denotes tumor

Allie

Id Subject Object Predicate Lexical cue
SS1_20696700_2_0 326-336 expanded denotes mutant p53
SS2_20696700_2_0 338-345 abbr denotes mut-p53
SS1_20696700_3_0 404-420 expanded denotes gain of function
SS2_20696700_3_0 422-425 abbr denotes GOF
SS1_20696700_5_0 674-682 expanded denotes knockout
SS2_20696700_5_0 684-686 abbr denotes KO
AE1_20696700_2_0 SS1_20696700_2_0 SS2_20696700_2_0 abbreviatedTo mutant p53,mut-p53
AE1_20696700_3_0 SS1_20696700_3_0 SS2_20696700_3_0 abbreviatedTo gain of function,GOF
AE1_20696700_5_0 SS1_20696700_5_0 SS2_20696700_5_0 abbreviatedTo knockout,KO

kaiyin_test

Id Subject Object Predicate Lexical cue
T1 0-6 Var denotes Mutant
T2 7-10 Gene denotes p53
T3 11-22 PosReg denotes facilitates
T4 23-49 CPA denotes somatic cell reprogramming
T5 54-62 NegReg denotes augments
T6 67-108 CPA denotes malignant potential of reprogrammed cells
T7 110-113 Gene denotes p53
T8 114-124 Var denotes deficiency
T9 125-133 PosReg denotes enhances
T10 152-178 CPA denotes somatic cell reprogramming
T11 254-267 Var denotes mutated forms
T12 271-274 Gene denotes p53
T13 275-279 PosReg denotes gain
T14 286-296 MPA denotes activities
T15 404-408 PosReg denotes gain
T16 412-420 MPA denotes function
T17 440-447 Var denotes mut-p53
T18 464-472 PosReg denotes enhanced
T19 495-516 CPA denotes reprogramming process
T21 571-579 MPA denotes activity
T20 583-590 Var denotes mut-p53
T22 599-610 Reg denotes alterations
T23 618-659 CPA denotes characteristics of the reprogrammed cells
T27 748-768 MPA denotes pluripotent capacity
T24 808-814 Var denotes mutant
T25 815-818 Gene denotes p53
T26 819-823 NegReg denotes lost
T28 844-853 Reg denotes gave rise
T29 857-873 CPA denotes malignant tumors
T30 1054-1072 MPA denotes oncogenic activity
T34 1089-1103 PosReg denotes overexpression
T31 1114-1131 Var denotes p53 KO or mut-p53
T32 1138-1145 PosReg denotes induced
T33 1146-1163 CPA denotes aggressive tumors
T35 1380-1383 Gene denotes p53
T36 1387-1394 Var denotes mutated
T37 1396-1409 CPA denotes reprogramming
T38 1414-1423 Reg denotes result in
T39 1442-1486 CPA denotes cells with malignant tumor-forming potential
R1 T2 T1 ThemeOf p53,Mutant
R10 T14 T13 ThemeOf activities,gain
R11 T12 T11 ThemeOf p53,mutated forms
R12 T17 T15 CauseOf mut-p53,gain
R13 T16 T15 ThemeOf function,gain
R14 T17 T18 CauseOf mut-p53,enhanced
R15 T19 T18 ThemeOf reprogramming process,enhanced
R16 T21 T20 ThemeOf activity,mut-p53
R17 T20 T22 CauseOf mut-p53,alterations
R18 T23 T22 ThemeOf characteristics of the reprogrammed cells,alterations
R19 T24 T26 CauseOf mutant,lost
R2 T1 T3 CauseOf Mutant,facilitates
R20 T27 T26 ThemeOf pluripotent capacity,lost
R21 T25 T24 ThemeOf p53,mutant
R22 T24 T28 CauseOf mutant,gave rise
R23 T29 T28 ThemeOf malignant tumors,gave rise
R24 T34 T31 ThemeOf overexpression,p53 KO or mut-p53
R25 T31 T32 CauseOf p53 KO or mut-p53,induced
R26 T33 T32 ThemeOf aggressive tumors,induced
R27 T30 T31 ThemeOf oncogenic activity,p53 KO or mut-p53
R28 T35 T36 ThemeOf p53,mutated
R29 T36 T37 CauseOf mutated,reprogramming
R3 T4 T3 ThemeOf somatic cell reprogramming,facilitates
R30 T37 T38 CauseOf reprogramming,result in
R31 T39 T38 ThemeOf cells with malignant tumor-forming potential,result in
R4 T1 T5 CauseOf Mutant,augments
R5 T6 T5 ThemeOf malignant potential of reprogrammed cells,augments
R6 T7 T8 ThemeOf p53,deficiency
R7 T8 T9 CauseOf deficiency,enhances
R8 T10 T9 ThemeOf somatic cell reprogramming,enhances
R9 T11 T13 CauseOf mutated forms,gain

name_no

Id Subject Object Predicate Lexical cue
T1 0-6 Var denotes Mutant
T2 7-10 Gene denotes p53
T3 11-22 PosReg denotes facilitates
T4 23-49 CPA denotes somatic cell reprogramming
T5 54-62 NegReg denotes augments
T6 67-108 CPA denotes malignant potential of reprogrammed cells
T7 110-113 Gene denotes p53
T8 114-124 Var denotes deficiency
T9 125-133 PosReg denotes enhances
T10 152-178 CPA denotes somatic cell reprogramming
T11 254-267 Var denotes mutated forms
T12 271-274 Gene denotes p53
T13 275-279 PosReg denotes gain
T14 286-296 MPA denotes activities
T15 404-408 PosReg denotes gain
T16 412-420 MPA denotes function
T17 440-447 Var denotes mut-p53
T18 464-472 PosReg denotes enhanced
T19 495-516 CPA denotes reprogramming process
T21 571-579 MPA denotes activity
T20 583-590 Var denotes mut-p53
T22 599-610 Reg denotes alterations
T23 618-659 CPA denotes characteristics of the reprogrammed cells
T27 748-768 MPA denotes pluripotent capacity
T24 808-814 Var denotes mutant
T25 815-818 Gene denotes p53
T26 819-823 NegReg denotes lost
T28 844-853 Reg denotes gave rise
T29 857-873 CPA denotes malignant tumors
T30 1054-1072 MPA denotes oncogenic activity
T34 1089-1103 PosReg denotes overexpression
T31 1114-1131 Var denotes p53 KO or mut-p53
T32 1138-1145 PosReg denotes induced
T33 1146-1163 CPA denotes aggressive tumors
T35 1380-1383 Gene denotes p53
T36 1387-1394 Var denotes mutated
T37 1396-1409 CPA denotes reprogramming
T38 1414-1423 Reg denotes result in
T39 1442-1486 CPA denotes cells with malignant tumor-forming potential
R1 T2 T1 ThemeOf p53,Mutant
R10 T14 T13 ThemeOf activities,gain
R11 T12 T11 ThemeOf p53,mutated forms
R12 T17 T15 CauseOf mut-p53,gain
R13 T16 T15 ThemeOf function,gain
R14 T17 T18 CauseOf mut-p53,enhanced
R15 T19 T18 ThemeOf reprogramming process,enhanced
R16 T21 T20 ThemeOf activity,mut-p53
R17 T20 T22 CauseOf mut-p53,alterations
R18 T23 T22 ThemeOf characteristics of the reprogrammed cells,alterations
R19 T24 T26 CauseOf mutant,lost
R2 T1 T3 CauseOf Mutant,facilitates
R20 T27 T26 ThemeOf pluripotent capacity,lost
R21 T25 T24 ThemeOf p53,mutant
R22 T24 T28 CauseOf mutant,gave rise
R23 T29 T28 ThemeOf malignant tumors,gave rise
R24 T34 T31 ThemeOf overexpression,p53 KO or mut-p53
R25 T31 T32 CauseOf p53 KO or mut-p53,induced
R26 T33 T32 ThemeOf aggressive tumors,induced
R27 T30 T31 ThemeOf oncogenic activity,p53 KO or mut-p53
R28 T35 T36 ThemeOf p53,mutated
R29 T36 T37 CauseOf mutated,reprogramming
R3 T4 T3 ThemeOf somatic cell reprogramming,facilitates
R30 T37 T38 CauseOf reprogramming,result in
R31 T39 T38 ThemeOf cells with malignant tumor-forming potential,result in
R4 T1 T5 CauseOf Mutant,augments
R5 T6 T5 ThemeOf malignant potential of reprogrammed cells,augments
R6 T7 T8 ThemeOf p53,deficiency
R7 T8 T9 CauseOf deficiency,enhances
R8 T10 T9 ThemeOf somatic cell reprogramming,enhances
R9 T11 T13 CauseOf mutated forms,gain